SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,517.84 |
| Enterprise Value ($M) | 2,602.54 |
| Book Value ($M) | 232.02 |
| Book Value / Share | 4.83 |
| Price / Book | 10.85 |
| NCAV ($M) | -49.24 |
| NCAV / Share | -1.03 |
| Price / NCAV | -51.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.15 |
| Current Ratio | 3.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 386.63 |
| Assets | 667.89 |
| Liabilities | 435.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | |||
| 13G/A | Eventide Asset Management, Llc | |||
| 13G/A | Biotechnology Value Fund L P | 6.40 | -29.61 | |
| 13G/A | BlackRock, Inc. | 7.10 | 0.00 | |
| 13G | Vanguard Group Inc | 5.31 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 83,170 | 536,048 | 15.52 | |
| 271,267 | 781,268 | 34.72 | |
| 63,974 | 461,706 | 13.86 | |
| 74,673 | 512,655 | 14.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LRMR – Larimar Therapeutics, Inc. | LXEO – Lexeo Therapeutics, Inc. |
| MDWD – MediWound Ltd. | MNKD – MannKind Corporation |
| MNOV – MediciNova, Inc. |
Financial data and stock pages provided by
Fintel.io